Symphony finances development of three Lexicon candidates; Lexicon later reacquires development rights
Lexicon Pharmaceuticals and private equity company Symphony Capital have formed Symphony Icon, a financing vehicle, with $45mm to fund development of Lexicon's three most advanced candidates over a four-year period.
Drug Discovery Tools
- Drug Discovery Tools
- Private Placement
- Special-Purpose Financing Vehicle
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.